<SEC-DOCUMENT>0001140361-22-031997.txt : 20220901
<SEC-HEADER>0001140361-22-031997.hdr.sgml : 20220901
<ACCEPTANCE-DATETIME>20220901164507
ACCESSION NUMBER:		0001140361-22-031997
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220721
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220901
DATE AS OF CHANGE:		20220901

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brooklyn ImmunoTherapeutics, Inc.
		CENTRAL INDEX KEY:			0000748592
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				311103425
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11460
		FILM NUMBER:		221221451

	BUSINESS ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220
		BUSINESS PHONE:		(212) 582-1199

	MAIL ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN BUZZTIME INC
		DATE OF NAME CHANGE:	20051230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN COMMUNICATIONS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALROY INDUSTRIES INC
		DATE OF NAME CHANGE:	19850411
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>brhc10041542_8ka.htm
<DESCRIPTION>8-K/A
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:btx="http://brooklynitx.com/20220721" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: broadridge
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_e6353bdccf7a4d55a4670c8333bdf6a9" contextRef="c20220721to20220721" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_53451111fb104cc593f8f9689ed5f5bf" contextRef="c20220721to20220721">0000748592</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="btx-20220721.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20220721to20220721"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-21</xbrli:startDate><xbrli:endDate>2022-07-21</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <hr style="border-width: 4px medium 1px; border-style: solid none; border-color: black -moz-use-text-color; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; border-image: none; height: 10px; color: rgb(255, 255, 255); background-color: rgb(255, 255, 255); text-align: center; margin-left: auto; margin-right: auto;" />
<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
      </span></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_45e7f56145994bde9ece646b6a545f88" contextRef="c20220721to20220721">8-K/A</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Amendment No. 1)</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
      </span></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
      </span></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Date of Report (Date of earliest event reported): <span style="font-weight: bold;"><ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_ab6f138dbfa34364a905bc48218a4e0a" contextRef="c20220721to20220721" format="ixt:datemonthdayyearen">July 21, 2022</ix:nonNumeric></span></div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
      </span></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_a2b576c7b9af49f4a620a68e99b7eb9d" contextRef="c20220721to20220721">Brooklyn ImmunoTherapeutics, Inc.</ix:nonNumeric><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">(Exact Name of Registrant as Specified in its Charter)</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
      </span></div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32.61%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_1e94b3adbcf240dabfd703a55431e0b7" contextRef="c20220721to20220721" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 33.68%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_ad564dabd9dd41c5ac5eb1b6fec558ff" contextRef="c20220721to20220721">001-11460</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 33%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_b5e128b4d88248268adc425475c3412c" contextRef="c20220721to20220721">31-1103425</ix:nonNumeric><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 32.61%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-style: italic;">(State or Other Jurisdiction of Incorporation)</div>
          </td>

    <td style="width: 33.68%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-style: italic;">(Commission File Number)</div>
          </td>

    <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-style: italic;">(IRS Employer Identification No.)</div>
          </td>

  </tr>


</table>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.01%; vertical-align: bottom;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_08b412bebb9b4e30a65700a8fa329d3e" contextRef="c20220721to20220721">10355 Science Center Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_284b9f8fecbe4831a72ca4aa1afadcb5" contextRef="c20220721to20220721">Suite 150</ix:nonNumeric></div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_2bb0fe8eebdb4a0e81fb3adce5b04541" contextRef="c20220721to20220721">San Diego</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_1053604ccc7b415c8ce3c745abae5965" contextRef="c20220721to20220721" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></div>
          </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> &#160;</span></div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_789ed306c1364c8d9f820a1cc9ba6588" contextRef="c20220721to20220721">92121</ix:nonNumeric><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 49.01%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-style: italic;">(Address of Principal Executive Offices)</div>
          </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-style: italic;">(Zip Code)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Registrant&#8217;s telephone number, including area code: <span style="font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_e4365b52fb5b45e2a1f850ef9b760555" contextRef="c20220721to20220721">212</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_f27da2b4bce84ea7be8936a6c7dce801" contextRef="c20220721to20220721">582-1199</ix:nonNumeric></span></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
      provisions:</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_c02819d27e8742c8a7d8933d7e7ee3f3" contextRef="c20220721to20220721" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>


</table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_ea797d60a11b40eaac9281c62dd00ea5" contextRef="c20220721to20220721" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
          </td>

  </tr>


</table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_bcada7defb2e483a9c6f9caa4cbb99c4" contextRef="c20220721to20220721" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
          </td>

  </tr>


</table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_d959178f5c274dbab908731f8b2d6d2b" contextRef="c20220721to20220721" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;">Title of each class</div>
          </td>

    <td style="width: 2%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;">Trading symbol</div>
          </td>

    <td style="width: 2%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;">Name of each exchange on which registered</div>
          </td>

  </tr>

  <tr>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_919bb5812fde4c8a8baed9df2a03f4d6" contextRef="c20220721to20220721">Common Stock, par value $0.005 per share</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 2%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_4f7384b65601471c9b1ee52d2e1c7a99" contextRef="c20220721to20220721">BTX</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 2%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_13b86bbdaffe41f4ba6414cd8699bc1c" contextRef="c20220721to20220721" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric><br />
            </div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange
      Act of 1934:</div>

    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_ed1ccead57fb48d3a7365fa9b04f83db" contextRef="c20220721to20220721" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric> </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
      financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
<div><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span></div>
</div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; color: rgb(0, 0, 0); font-weight: bold;">Explanatory Note</div>

    </div>

    <div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">This Current Report on Form 8-K/A (this &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">Amendment</span></span>&#8221;) is being filed as
          an amendment to the Current Report on Form 8-K filed by Brooklyn ImmunoTherapeutics, Inc., a Delaware corporation (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">Company</span></span>&#8221;), with the Securities and Exchange
          Commission on July 27, 2022 (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">Original 8-K</span></span>&#8221;). The purpose of this Amendment is to update the disclosure under &#8220;Item 5.02 Departure of Directors or Certain Officers;
          Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers&#8221; of the Original 8-K to provide the effective date of Dr. Kevin D&#8217;Amour&#8217;s resignation as Chief Scientific Officer of the Company.&#160; As previously
          reported, at the time of the Original 8-K, Dr. D&#8217;Amour had delivered his notice of resignation, but his date of resignation had not yet been determined.&#160; <span style="font-size: 10pt; font-family: 'Times New Roman';">This Amendment additionally
            includes a description and a copy of the separation agreement entered into by the Company and Dr. D&#8217;Amour on August 26, 2022.&#160; </span>No other changes are being made to the Original 8-K.</div>

        <div>&#160;</div>

      </div>

    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.02</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Departure of Directors or Certain Officers; Election of Directors; Appointment of
                Certain Officers; Compensatory Arrangements of Certain Officers.</span></div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div>
      <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On July 21, 2022, Dr. Kevin D&#8217;Amour, Chief Scientific Officer of Brooklyn ImmunoTherapeutics, Inc., a Delaware corporation (the &#8220;<span style="text-decoration: underline;">Company</span>&#8221;),





        delivered his notice of resignation. Dr. D&#8217;Amour&#8217;s resignation became effective on August 26, 2022.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    </div>

    <div>
      <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In connection with Dr. D&#8217;Amour&#8217;s resignation, on August 2<span style="font-size: 10pt; font-family: 'Times New Roman';">6</span>,
          2022, the Company entered into a Separation Agreement and General Release with Dr. D&#8217;Amour (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">Separation Agreement</span></span>&#8221;), pursuant to which Dr. D&#8217;Amour resigned from his
          positions as Chief Scientific Officer and as an officer, director and employee of the Company and all subsidiaries<span style="font-size: 10pt; font-family: 'Times New Roman';"> as of August 26, 2022</span>. In consideration for Dr. D&#8217;Amour&#8217;s
          execution of the Separation Agreement and non-revocation of a waiver and release of claims relating thereto, Dr. D&#8217;Amour will be entitled to the following benefits under the Separation Agreement:</div>

        <div>&#160;</div>

      </div>

    </div>

    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: Times New Roman">&#9679;</span></td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">payment of Dr. D&#8217;Amour&#8217;s annual base salary for a period of nine (9) months after the expiration of
                  the applicable revocation period (the &#8220;<span style="text-decoration: underline;">Separation Period</span>&#8221;), for a total gross amount equal to $311,250;</span></div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: Times New Roman">&#9679;</span></td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">payment of Dr. D&#8217;Amour&#8217;s premiums for continued health benefits provided under COBRA for the Separation Period; and</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: Times New Roman">&#9679;</span></td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">the vested portions of all Dr. D&#8217;Amour&#8217;s outstanding options, representing 57,296 shares of the Company&#8217;s common stock,&#160; shall be eligible to be exercised for a period of ninety (90) days following the
                separation date, and all unvested options, restricted stock units and performance stock units were immediately forfeited as of the separation date.</div>
            </td>

  </tr>


</table>
    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
      <div><br />
      </div>

    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Under the Separation Agreement, Dr. D&#8217;Amour has agreed to cooperate with and assist the Company regarding certain matters and transitioning his employment duties and
        responsibilities. Subject to certain exceptions and limitations, the Separation Agreement includes a general release of claims by Dr. D&#8217;Amour in favor of the Company and certain related persons and parties, and customary confidentiality provisions.
        The Separation Agreement also includes certain other customary representations, warranties and covenants of Dr. D&#8217;Amour, and provides for reimbursement of certain expenses incurred by Dr D&#8217;Amour. The Separation Agreement supersedes all other
        agreements or arrangements between Dr. D&#8217;Amour and the Company regarding the subject matter of the agreement, including those with respect to severance payments and benefits.</div>

    </div>

    <div>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </span></div>

    </div>

    <div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description of the Separation Agreement is only a summary and is qualified in its entirety by reference to the full text of such
          agreement, which is filed as Exhibit 10.1 to this <span style="font-size: 10pt; font-family: 'Times New Roman';">Amendment</span> and is incorporated by reference in this Item 5.02.</div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>

      </div>

    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="font-weight: bold;">Financial Statements and Exhibits.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">(d) Exhibits.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 14%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number</div>
            </div>
          </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 83.82%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;">
            <div>
              <div style="font-weight: bold;">Description</div>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 14%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10041542_ex10-1.htm">10.1<span style="font-size: 10pt; font-family: 'Times New Roman';">**</span></a></div>
            </div>
          </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 83.82%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Separation Agreement and General Release, dated August 24, 2022, by and between
                Brooklyn ImmunoTherapeutics, Inc. and Kevin D&#8217;Amour</span><span style="font-family: 'Times New Roman'; font-size: 10pt;">.</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 14%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">104</div>
          </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 83.82%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">** </span>Management contract or compensation plan or arrangement.</div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto
      duly authorized.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50.33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left; font-variant: small-caps;">Brooklyn ImmunoTherapeutics, Inc.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50.33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50.33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Dated: September 1<span style="color: rgb(0, 0, 0);">, 2022</span></div>
          </td>

    <td style="width: 2.99%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">By:</div>
          </td>

    <td style="width: 46.57%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">/s/ Andrew Jackson</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50.33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 2.99%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 46.57%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Chief Financial Officer</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

  </div>

  <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" />
<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>brhc10041542_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit, a Broadridge Company
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 10.1</font><br>
  </div>
  <div> <br>
  </div>
  <div> <img src="logo01.jpg"></div>
  <br>
  <div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">August 24, 2022</font></div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Kevin D&#8217;Amour </font></div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Via email</font></div>
    <div>&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z9571417005b9425098f78d87a0c6c122" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="width: 36pt;">&#160;</td>
            <td style="vertical-align: top; width: 27pt;">
              <div style="text-align: left;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic;">RE:</font></div>
            </td>
            <td style="vertical-align: top; width: auto;">
              <div style="text-align: left;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Separation Agreement and General Release</font></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Dear Kevin:</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">The purpose of this separation agreement (the <u>&#8220;</u><u>Separa</u><u>tion </u><u>Agreement&#8221;)</u>
        is to memorialize the terms and conditions of the separation of your employment with Brooklyn ImmunoTherapeutics, Inc. (the <u>&#8220;Co</u><u>mpany</u><u>&#8221;)</u>&#160;and its subsidiaries and affiliates (together with the Company collectively, the <u>&#8220;Company





          Group&#8221;),</u> as well as that certain Executive Employment Agreement, dated June 5, 2021, by and between YOU (the terms &#8220;YOU&#8221; and &#8220;YOUR&#8221; refers to Kevin D&#8217; Amour) and the Company (the <u>&#8220;E</u><u>mploymen</u><u>t </u><u>Agreement&#8221;)</u>.&#160;Capitalized







        terms used but not defined here in shall have the meanings ascribed thereto in the Employment Agreement.</font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">To ensure that YOUR separation from the Company occurs on mutually acceptable terms,
        this Separation Agreement, along with the General Release of Claims on </font><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Exhibit A,</u>&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">attached


        hereto and made a part hereof (the <u>&#8220;Ge</u><u>neral Release</u><u>&#8221;</u><u>)</u>,&#160;will summarize the terms and conditions surrounding YOUR separation including, without limitation, the compensation, and benefits that will be provided
        to YOU.</font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Separation Date</u></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">The effective date of the separation of YOUR employment, and the Employment Agreement,
        is </font><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">August 26, 2022 </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>(&#8220;Separation Date</u><u>&#8221;</u><u>).</u></font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Resignation as Officer </u><u>and Director of the Company </u><u>Group</u></font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">YOU acknowledge and agree that, effective as of the Separation Date, YOU will be deemed
        to have resigned from all positions then held as an officer as well as a member of any board of directors, and any committee thereto, throughout the Company Group.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Accrued Obligations</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Whether or not YOU choose to sign this Separation Agreement and the General Release,
        the Company will pay to YOU any (a) accrued but unpaid base salary YOU have earned through the Separation Date, (b) accrued but unused paid time off through the Separation Date (c) reimbursement for unreimbursed business expenses properly incurred
        by YOU pursuant to the Company&#8217;s applicable expense reimbursement policy; and (d) any accrued but unpaid benefits provided under the Company&#8217;s employee benefit plans, subject to and in accordance with the terms of those plans, in each case, less
        applicable withholding and employment taxes, all of which shall be paid to YOU by the Separation Date or such other date as required under the applicable employee benefit plan.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">For purposes of this Separation Agreement and the General Release, the amounts
        described above in this section shall be referred to as the <u>&#8220;Acc</u><u>rued </u><u>Obligations&#8221;.</u></font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Separation </u><u>Benefits</u></font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">In the event that YOU execute and deliver to the Company both the Separation Agreement
        and the General Release, and YOU do not revoke the General Release within the time period permitted by law (such period, the&#160; <u>&#8220;Revocatio</u><u>n&#160; </u><u>Period&#8221;</u>&#160; as&#160; defined&#160; below), the following shall apply (subject to any timing
        restrictions as may be applicable under Section 409A of the Internal Revenue Code of 1986, as amended (the <u>&#8220;</u><u>Code&#8221;)):</u></font></div>
    <div style="text-align: justify;">&#160;</div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z0f838c9c6cfa4ea299515fa4e990105a" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 36pt; text-align: justify;">&#160;</td>
              <td style="vertical-align: top; width: 27pt;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: Times New Roman">&#9679;</font></div>
              </td>
              <td style="align: left; vertical-align: top; width: auto;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Commencing on the first regular payroll date immediately following the end of the Revocation
                    Period, the Company shall continue to pay to YOU YOUR annual base salary for a period of nine (9) months thereafter (the&#160;<u>&#8220;Severance </u><u>Period&#8221;)</u> in accordance with the Company&#8217;s normal payroll processing, for a total gross
                    amount equal to $311,250 (less applicable income and employment tax withholdings).</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zfe2b9a3890154a35808affe81b395bc6" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: Times New Roman">&#9679;</font></td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">If YOU (or YOU and YOUR eligible dependents) timely and properly elects health insurance
                continuation rights under the Consolidated Omnibus Budget Reconciliation Act of 1985 (&#8220;COBRA&#8221;), the Company will pay the cost of the COBRA premiums until the earlier of (i) the last day of the Severance Period or (ii) the termination of
                YOUR rights&#160; under COBRA;&#160; provided,&#160; for the avoidance of doubt, that such covered dependents participated in the Company&#8217;s health plans prior to such separation, and provided, further, that if at any time the Company determines that its
                payment of YOUR (or YOUR eligible dependents&#8217; ) premiums would result in a violation of law, then in lieu of providing the premiums described above, the Company will instead pay YOU a fully taxable&#160; monthly cash&#160; payment in an amount equal
                to the applicable premiums for such month, with such monthly payment being made on the last day of each month for the remainder of the Severance Period.</font></div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">For purposes of this Separation Agreement and the General Release, the benefits
        described above in this section shall be referred to as the <u>&#8220;Separat</u><u>i</u><u>on </u><u>Benefits&#8221;</u>. Except for the Accrued Obligations, the payments from the Company to YOU pursuant to the terms of this Separation Agreement (including
        the Separation Benefits) are not provided as a raise, bonus, or condition of YOUR employment with the Company.</font></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">1<font style="font-family: 'Times New Roman'; font-size: 10pt;">0355 Science Center Drive, Suite 150, San Diego, CA 92121 | tel: (212) 582-1199 | brooklynitx.com </font></div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Mailing address: </font>1<font style="font-family: 'Times New Roman'; font-size: 10pt;">0531 4S Commons
        Drive, Suite 160-550, San Diego, CA 92127</font></div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">YOU acknowledge and agree that as of the Separation Date,&#160; this Separation&#160; Agreement&#160;
        and General Release shall supersede and replace all benefits, rights and obligations in connection with YOUR employment with the Company Group, except for those terms in the Employment Agreement that are specifically restated herein. Accordingly,
        YOU further acknowledge and agree that this Separation Agreement and the General&#160; Release sets forth&#160; all&#160; compensation&#160; and&#160; benefits to which YOU are entitled and shall be paid to YOU in full satisfaction thereof, in connection with your
        employment with the Company Group.</font></div>
    <div style="text-indent: 36pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">YOU also acknowledge and agree that the Separation Benefits to be paid under this
        Agreement is due solely from the Company and that Insperity PEO Services, L.P. <u>(</u><u>&#8220;</u><u>In</u><u>s</u><u>perity</u><u>&#8221;),</u>&#160;the professional employer organization retained by the Company, has no obligation to pay the Severance
        benefits, even though its payment may be processed through Insperity.</font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Equity </u><u>Awards</u></font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">YOU acknowledge and agree that as of the Separation Date:</div>
    <div style="text-align: left; color: rgb(49, 49, 49); font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z7c5f170790114451bb1c021130e83a3a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: Times New Roman">&#9679;</font></td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">The vested portion of the Option Grant (which specifically relates to </font><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>38,074</u> </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">shares of&#160; the&#160; Company) shall&#160; be eligible to be exercised&#160; for a period of
                ninety (90) days after the Separation Date pursuant to the terms and conditions of the Option Grant. The remainder of the Option Grant (which relates specifically to </font><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>102,506</u>&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">shares of the Company) is unvested and shall be immediately forfeited as of the Separation Date.</font></div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7bc89bee036e4542977dc35383304536" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: Times New Roman">&#9679;</font></td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">The unvested portion of the RSU Grant, which specifically relates to </font><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>52,717</u>&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">shares of the Company, shall be immediately forfeited as of the Separation Date.
                The vested portion of the RSU Grant, which specifically related to </font><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>17,573</u>&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">shares


                of the Company were previously vested pursuant to the terms and conditions of the RSU Grant.</font></div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zddae4552f6e54a4a83b75b4d40adbfb1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: Times New Roman">&#9679;</font></td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">The outstanding portion of the performance stock units granted to YOU on March 11, 2022 (the&#160;<u>&#8220;2</u><u>022


                </u><u>PSU Award&#8221;),</u> which specifically relates to </font><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">103,800 </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">shares of the
                Company, is unvested and shall be immediately forfeited as of the Separation Date. The remainder of the 2022 PSU Award, which specifically related to </font><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>34,600</u>&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">shares of the Company, were previously forfeited prior to the Separation Date pursuant to the terms and condition of the 2022 PSU Award.</font></div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z663fb17d92d34dfc820dcb5d62ddc313" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: Times New Roman">&#9679;</font></td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">The vested portion of the stock option granted to YOU on March 11, 2022 (the<u> &#8220;</u><u>2022
                  Option&#8221;</u><u>)</u> (which specifically relates to </font><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>19,222</u>&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">shares of the
                Company) shall be eligible to be exercised for a period of ninety (90) days after&#160; the&#160; Separation Date pursuant to the terms and conditions of the applicable stock option award agreement. The remainder of the 2022 Option (which relates
                specifically to </font><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>119,178</u>&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">shares of the Company) is unvested and shall be
                immediately forfeited as of the Separation Date.</font></div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">1<font style="font-family: 'Times New Roman'; font-size: 10pt;">0355 Science Center Drive, Suite 150, San Diego, CA 92121 | tel: (212) 582-1199 | brooklynitx.com </font></div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Mailing address: </font>1<font style="font-family: 'Times New Roman'; font-size: 10pt;">0531 4S Commons
          Drive, Suite 160-550, San Diego, CA 92127</font></div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">You acknowledge and agree that you do not have any rights with respect to any other
        equity awards or equity-based interests in the Company.</font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Agreement </u><u>Preparation and Negotiation Fees</u></font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Upon submission of invoices and other applicable documentation reasonably requested by
        the Company, the Company shall&#160; reimburse you for reasonable&#160; attorneys&#8217;&#160; fees and costs incurred by you in connection with your separation including the preparation and negotiation of this Separation Agreement and General Release, up to a maximum
        amount of $5,000.</font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Integration of </u><u>Employment </u><u>Agreement; Survival of Certain Provisions</u></font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">As of the Separation Date, YOU acknowledge and agree that this Separation Agreement shall supersede and replace the Employment
        Agreement, except for those provision that are specifically restated and incorporated by reference herein, in addition to the following provisions under the Employment Agreement (collectively, the <u>&#8220;S</u><u>urvival </u><u>Provisions&#8221;):</u>
        Section 6 (Company Property) provided you will be entitled to keep and not obligated to return to the Company your work laptop so long as all of the Company property, documents and confidential information are removed from such laptop; Section 9
        (Protection of Confidential Information); Section 10 (Intellectual Property); Section 11 (Publicity; Non-disparagement), except the parties agree that nothing in this Separation Agreement or the Employment Agreement prevents YOU from discussing or
        disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that YOU have reason to believe is unlawful; Section 20 (Dispute Resolution) and Section 21 (Indemnification) <u>which shall
          remain </u><u>in </u><u>full force and </u><u>e</u><u>ffect</u>&#160;except the parties agree that (a) individual claims under the Private Attorneys General Act can be subject to arbitration under that Section 20 and (b) the following claims are
        excluded from the scope of that Section 20: (i) claims under the National Labor Relations Act, (ii) claims under the California Workers&#8217; Compensation Act, (iii) claims for unemployment compensation benefits, (iv)</font> <font style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">claims for benefits under a plan that is governed by the Employee Retirement Income Security Act of 1974, (v) claims that are subject to the Ending
          Forced Arbitration of Sexual Assault and Sexual Harassment Act, or (vi) claims that are expressly prohibited from mandatory arbitration under applicable law. Accordingly, YOU further acknowledge and agree that (i) this Separation Agreement sets
          fo1th all compensation and benefits to which YOU are&#160; entitled&#160; under&#160; YOUR Employment Agreement; and (ii) in the event that YOU breach any of the Survival Provisions, the Separation Benefits shall cease immediately and YOU will no longer be
          entitled to such benefits.</font></font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Release Of </u><u>Claims </u><u>Against </u><u>The </u><u>Company Group</u></font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">In exchange&#160; for&#160; and&#160; as a condition to receiving&#160; the Separation Benefits, YOU&#160; shall
        knowingly and willingly release the Company Group from any kind of claim YOU have arising out of or related to YOUR employment, the Employment Agreement and/or the termination of YOUR employment with the Company Group by executing the General
        Release attached hereto as <u>Exhibit A</u>.</font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">1<font style="font-family: 'Times New Roman'; font-size: 10pt;">0355 Science Center Drive, Suite 150, San Diego, CA 92121 | tel: (212) 582-1199 | brooklynitx.com </font></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Mailing address: </font>1<font style="font-family: 'Times New Roman'; font-size: 10pt;">0531 4S Commons
          Drive, Suite 160-550, San Diego, CA 92127</font></div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">YOU will be required to execute the General Release, and therefore
        agree to be bound by the terms and conditions thereof, no earlier than the Separation Date but no later than thirty (30) days after such Separation Date.</font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Cooperation</u><u>/</u><u>Assistance</u></font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Cooperat</u><u>i</u><u>o</u><u>n </u><u>and Assi</u><u>s</u><u>tance:</u>&#160;Upon
        reasonable notice&#160; and at reasonable times, YOU agree to assist and cooperate with the Company, by telephone or video conference or otherwise, concerning business or legal related matters about which YOU possess relevant knowledge or information.
        Such cooperation shall only be provided at the Company&#8217;s specific request and will include, but not be limited to, assisting or advising the Company with respect to any&#160; business-related matters or any actual or threatened legal action (including
        testifying in depositions, hearings, and /or trials) about which YOU possess relevant knowledge or information. In addition, you agree to promptly inform the Company if any person or entity contacts YOU in an effort to obtain information about the
        Company. The Company agrees to reimburse YOU for all reasonable and necessary costs and expenses incurred in connection with such cooperation and will compensate YOU at a reasonable rate for time spent by YOU at the Company&#8217;s request in connection
        with such cooperation.</font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Severability;</u>&#160;<u>Enti</u><u>re </u><u>Agreement; No Oral </u><u>Mod</u><u>ifications;








        </u><u>N</u><u>o </u><u>Waivers</u></font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">If a court of competent jurisdiction determines that any of the provisions of this
        Agreement are invalid or legally unenforceable, all other provisions of this Agreement shall not be affected and are still enforceable. This Separation Agreement and the General Release are intended to be a single integrated contract expressing our
        entire understanding regarding&#160; the subjects&#160; it addresses. As such, it supersedes all oral and written agreements, promises, representations&#160; and discussions that occurred before the time YOU sign each of them except as to any obligations YOU may
        owe to the Company Group as described in the </font><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">&#8220;Integration of Employment Agreement; Survival of Certain Provisions&#8221; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">section above that remain in effect and for the avoidance of doubt, no extrinsic evidence may be introduced in any judicial proceeding or arbitration involving this Separation Agreement. This Separation Agreement and
        the General Release may be amended or modified only by an agreement in writing signed by YOU and counter signed by an executive officer of the Company. The failure by the Company or YOU (i) to declare a breach, or (ii) to otherwise assert rights
        under this Agreement shall not be construed as a waiver of any of rights under this Separation Agreement and the General Release. This Separation Agreement and the General Release may be executed and delivered (including by facsimile or other
        electronic transmission) in one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original, but all of which taken together shall constitute one and the same
        instrument.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">1<font style="font-family: 'Times New Roman'; font-size: 10pt;">0355 Science Center Drive, Suite 150, San Diego, CA 92121 | tel: (212) 582-1199 | brooklynitx.com </font></div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Mailing address: </font>1<font style="font-family: 'Times New Roman'; font-size: 10pt;">0531 4S Commons
        Drive, Suite 160-550, San Diego, CA 92127</font></div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Governing </u><u>Law; Venue</u></font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">This Separation Agreement and the General Release shall be governed by the laws of the&#160;
        State of California applicable to contracts executed&#160; and&#160; performed&#160; within&#160; that State and&#160; without respect to conflict of laws principles. The parties hereto irrevocably and unconditionally (i) agree that any suit, action or legal proceeding
        arising out&#160; of or relating to&#160; this Agreement shall be brought in the courts of record of the State of California or the court of&#160; the United States, Southern&#160; District of California; and (ii) consent to the jurisdiction of each such court in any
        suit, action&#160; or proceeding.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Acknowledgements </u><u>and Certifications</u></font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">YOU acknowledge and certify that:</font></div>
    <div style="text-align: justify;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z614ae1c0917f4210b9be80fdb5e62b53" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: Times New Roman">&#9679;</font></td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">YOU have read and YOU understand all of the terms of this Separation Agreement and the General
                Release on&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Exhibit&#160; A,</u>&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">and are&#160; not&#160; relying&#160; on&#160; any&#160; representation or
                statement, written or oral, not set forth in this Separation Agreement and the General Release;</font></div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zd32b4126aa10419abad007bcabd180e1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: Times New Roman">&#9679;</font></td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">YOU are signing this Separation Agreement, and shall sign the General Release, knowingly and
                voluntarily;</font></div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z51f63a38c7c14b1bba3d53596230e327" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: Times New Roman">&#9679;</font></td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">YOU have been advised to consult with an attorney before signing this Separation Agreement and the
                General Release ;</font></div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z39caaf53d8a342b4b72de941b993473a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: Times New Roman">&#9679;</font></td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">YOU have the right to consider the terms of this Separation Agreement and the General Release for
                21 days; however, YOU do not have to take all&#160; 21 days to consider it, and if YOU take fewer than 21 days to review this Separation Agreement and the General Release,&#160; YOU&#160; expressly waive any and&#160; all&#160; rights to consider this Separation
                Agreement and the General Release for the balance of the 21-day review period; and</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z6a99e4bdac8e4184a1113b1d449f6a10" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: Times New Roman">&#9679;</font></td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">the General Release includes a release of any claim YOU might have under the ADEA (the&#160;<u>&#8220;ADEA </u><u>C</u><u>l</u><u>a</u><u>im</u><u>s&#8221;).</u>
                For seven (7) days&#160; after signing&#160; the&#160; General Release, YOU have the right to revoke YOUR release of ADEA Claims (the<u> &#8220;</u><u>Revocation Period</u><u>&#8221;</u><u>)</u>. To revoke YOUR release&#160; of&#160; ADEA Claims, the revocation or rescission
                must be in writing and must be delivered by hand or sent by certified mail , return receipt requested, postmarked with in the seven (7) day period, and properly addressed to the Chairman of the Company at&#160; 10355 Science Center </font>Drive,


              Suite 150, San Diego, CA 92121. Revoking YOUR release of ADEA Claims shall result in the invalidation of this Separation Agreement, in its entirety, as of such revocation date; and</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">1<font style="font-family: 'Times New Roman'; font-size: 10pt;">0355 Science Center Drive, Suite 150, San Diego, CA 92121 | tel: (212) 582-1199 | brooklynitx.com </font></div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Mailing address: </font>1<font style="font-family: 'Times New Roman'; font-size: 10pt;">0531 4S Commons
        Drive, Suite 160-550, San Diego, CA 92127</font></div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font>
      <table cellspacing="0" cellpadding="0" id="zd6919f6477064e52a098acb7b950242d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: Times New Roman">&#9679;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">YOU and the Company and Parent each agree that any changes that have been made to this Separation Agreement and the General Release from the versions
                originally presented to YOU do not extend the 21-day period YOU have been given to consider this Separation Agreement and the General Release, whether those changes are deemed material or non-material.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: 36pt;">IF YOU SIGN THIS DOCUMENT AND EXHIBIT A ATTACHED HERETO, IT BECOMES A LEGALLY ENFORCEABLE AGREEMENT EFFECTIVE ON THE DATE SIGNED
        BY THE COMPANY.</div>
      <div>&#160;</div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zdafad1ca1a254af695ab7adddf1b34b4">

          <tr>
            <td style="width: 50%; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Dated:&#160; August 26, 2022</div>
            </td>
            <td style="width: 30%; font-weight: normal; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">/s/ KEVIN D&#8217;AMOUR</div>
            </td>
            <td style="width: 20%; font-weight: normal; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%;"><br>
            </td>
            <td colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">KEVIN D&#8217;AMOUR</div>
              </div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 50%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Dated:&#160; August 26, 2022</div>
            </td>
            <td colspan="3">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS, INC.<br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%;"><br>
            </td>
            <td colspan="3"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; padding-bottom: 2px;"><br>
            </td>
            <td style="padding-bottom: 2px; width: 4%;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">By:</font></td>
            <td style="border-bottom: 2px solid rgb(0, 0, 0); width: 30%;">/s/ Matt Angel</td>
            <td style="padding-bottom: 2px; width: 16%;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%;"><br>
            </td>
            <td colspan="3">Name: Matt Angel<br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%;"><br>
            </td>
            <td colspan="3">Title: CEO<br>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <br>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1<font style="font-family: 'Times New Roman'; font-size: 10pt;">0355 Science Center Drive, Suite 150, San Diego, CA 92121 | tel: (212) 582-1199 | brooklynitx.com </font></div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Mailing address: </font>1<font style="font-family: 'Times New Roman'; font-size: 10pt;">0531 4S Commons
            Drive, Suite 160-550, San Diego, CA 92127</font></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"> <br>
        </font></div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%A-%%-->
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>EXHIBIT A</u></div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>GENERAL RELEASE OF CLAIMS</u></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">In exchange for the Separation Benefits described in that certain Separation&#160; and Release Agreement (the&#160;<u>&#8220;Co</u><u>mpan</u><u>y&#8221;),</u>&#160; dated&#160; August 24, 2022&#160; (the &#160;<u>&#8220;Se</u><u>para</u><u>t</u><u>ion&#160; </u><u>Agreement&#8221;)</u>&#160;
          to which this General Release of Claims is attached as&#160;<u>Ex</u><u>hibit </u><u>A</u> thereto, Kevin&#160; D&#8217;Amour<u> (&#8220;Executive&#8221;)</u>, for himself and his family, heirs, executors, administrators,&#160; legal&#160; representatives and their respective
          successors and assigns, does hereby release and forever discharge Brooklyn ImmunoTherapeutics, Inc. (the&#160;<u>&#8220;C</u><u>ompany&#8221;)</u> and its subsidiaries, affiliated companies, successors and assigns (to get her with Company, the&#160;<u>&#8220;C</u><u>ompany
          </u><u>Gro</u><u>u</u><u>p&#8221;)</u>&#160;and&#160; Insperity PEO Services, L.P., the professional employer organization retained by the Company, and its current and former parent companies, subsidiaries and other affiliates (collectively,&#160;<u>&#8220;</u><u>Insperity</u><u>&#8221;</u><u>),</u>&#160;and


          their respective current or former directors, officers, employees, shareholders, insurers or agents in such capacities (collectively with the Company Group and Insperity, the <u>&#8220;</u><u>R</u><u>e</u><u>lea</u><u>sed&#160; </u><u>Parties</u><u>&#8221;</u><u>)</u>&#160;
          from&#160; any&#160; and&#160; all actions, causes of action, suits, controversies, claims and demands whatsoever, for or&#160; by reason&#160; of any matter, cause or thing whatsoever, whether known&#160; or unknown&#160; including,&#160; but&#160; not limited&#160; to, all claims under any
          applicable laws arising under or in connection with Executive&#8217;s employment or termination thereof, and/or in connection with or arising under the Employment Agreement (as defined in the Separation Agreement), whether for tort, breach of express
          or implied employment contract, wrongful discharge, intentional infliction of emotional distress, or defamation or injuries incurred on the job or incurred as a result of loss of employment. Executive acknowledges that the Company Group
          encouraged him to consult&#160; with&#160; an&#160; attorney&#160; of&#160; his&#160; choosing,&#160; and&#160; through&#160; this General Release of Claims encourages him to consult with his attorney with respect to possible claims under the Age Discrimination in Employment&#160; Act&#160;<u>(&#8220;ADEA&#8217;&#8217;)</u>&#160;and


          that he understands that the ADEA is a Federal statute that, among other things, prohibits discrimination on the&#160; basis&#160; of&#160; age in&#160; employment and employee benefits and benefit plans. Without limiting the generality of the release provided
          above, Executive expressly waives any and all claims under ADEA that he may have as of the date hereof. Executive further understands that by signing this General Release of Claims he&#160; is&#160; in fact waiving,&#160; releasing and forever giving&#160; up any
          claim&#160; under the&#160; ADEA as well as all other laws within the scope of this paragraph 1 that may have existed on or prior to the date hereof. Notwithstanding anything in this paragraph 1 to&#160; the&#160; contrary, this&#160; General&#160; Release&#160; of Claims shall
          not apply to (i) any rights to receive any payments or&#160; benefits pursuant to the Separation Agreement, (ii) any rights or claims that may arise as a&#160; result of events occurring after the date this General Release of Claims is executed, (iii) any
          indemnification&#160; rights&#160; Executive may have as a former officer or director of the Company Group, (iv) any claims for benefits under any directors&#8217; and officers&#8217; liability policy maintained&#160; by the Company Group in accordance with the terms of
          such policy, (v) any indemnification rights set forth in the parties&#8217; prior Employment Agreement; and (vi) any rights as a holder of equity securities of the Company.</font></font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Executive represents that he has not&#160; filed&#160; against&#160; the&#160; Released&#160; Parties&#160; any complaints, charges, or&#160; lawsuits arising out of his employment or under his Employment Agreement, or any
          other matter arising on&#160; or&#160; prior to the date of this&#160; General&#160; Release&#160; of&#160; Claims, and covenants and agrees that he will never individually or with any person file, or commence the filing of, any charges, lawsuits, complaints or proceedings
          with any governmental agency, or</font> against the Released Parties with respect to any of the matters released by Executive pursuant to paragraph 1 hereof (a <u>&#8220;Pro</u><u>ceeding&#8221;); provided</u><u>, </u><u>h</u><u>ow</u><u>ev</u><u>e</u><u>r</u>,
        that</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-1</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">a</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Nothing in this Agreement prohibits or prevents the&#160; Executive from&#160; filing a charge with or participating, testifying, or assisting in any investigation, hearing, or other proceeding before the U.S. Equal&#160;
          Employment Opportunity Commission, the National Labor Relations Board or a similar agency enforcing federal, state or local anti-discrimination laws. However, to the maximum extent permitted by law, the Executive agrees that if such an
          administrative claim is made to such an anti-discrimination agency, he shall not be entitled&#160; to&#160; recover any individual monetary relief&#160; or&#160; other&#160; individual remedies. In addition, nothing in this Agreement, including but not limited to the
          release of claims and non-disparagement clauses, prohibits the Executive from (A) reporting possible violations of federal law or regulations, including any possible securities laws violations, to any governmental agency or entity, including but
          not limited to the U.S. Department of Justice, the U.S. Securities and Exchange Commission, the U.S. Congress, or any agency Inspector General; (B) making any other disclosures that are protected under the whistleblower provisions of federal law
          or regulations; or (C) otherwise fully participating in any federal whistleblower programs, including but&#160; not&#160; limited to any such programs managed by the U.S. Securities and Exchange Commission and/or the Occupational Safety and Health
          Administration. Moreover, nothing in this Agreement prohibits or prevents the Executive from receiving individual monetary awards or other individual relief by virtue of participating in such federal whistleblower programs.</font></font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">b.&#160;&#160; &#160; &#160; &#160; &#160; Executive shall not have relinquished his right to
        commence a Proceeding to challenge whether Executive knowingly and voluntarily waived his rights under ADEA.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Executive acknowledges that Executive has been advised to consult with legal counsel and is familiar with the provisions of California Civil Code section 1542, a statute that otherwise prohibits the release of unknown Claims,
          which provides as follows:</font></font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES
        NOT KNOW OR SUSPECTS TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR THE RELEASED PARTY.</font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Being aware of said code section, Executive agrees to expressly waive any rights
        Executive may have thereunder, as well as under any other statute or common law&#160; principles of similar effect.</font></div>
    <div>&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-2</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Executive here by acknowledges that the Company Group has informed him that he has up to twenty-one (21) days to sign this General Release of Claims and he may knowingly and voluntarily waive that twenty-one (21) day period by
          signing this General Release of Claims earlier. Executive also understands that he shall have seven (7) days following the date on which he signs </font>this General Release of Claims within which to revoke the release of ADEA claims by
        providing written notice of his revocation to the Company Group (the <u>&#8220;Revocati</u><u>o</u><u>n Peri</u><u>o</u><u>d&#8221;)</u>.</font></div>
    <div>
      <div style="text-align: justify;">&#160;<br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">Executive acknowledges that this General Release of Claims will be governed by and construed and enforced in accordance with the internal laws of the State of California applicable to contracts made and to be performed
            entirely within such State.</font></font></div>
      <div style="text-align: justify;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">6. &#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; Executive acknowledges that he has read this General Release of Claims,
          that he has been advised that he should consult with an attorney before he executes this General Release of Claims, and that he understands all of its terms and executes it voluntarily and with full knowledge of its significance and the
          consequences thereof.</font></div>
      <div style="text-indent: 36pt; text-align: justify;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; This General Release of Claims shall take effect on the eighth day
          following Executive&#8217;s execution of this General Release of Claims unless Executive delivers written revocation(s) to the Company within the aforementioned Revocation Period.</font></div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zcb8d0f3e4051406e890b1b38c506cfac">

            <tr>
              <td style="width: 50%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
              <td style="width: 50%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ KEVIN D&#8217;AMOUR</td>
            </tr>
            <tr>
              <td style="width: 50%;">
                <div>&#160;</div>
              </td>
              <td style="width: 50.00%;"><font style="font-weight: bold;">KEVIN D&#8217;AMOUR</font><br>
              </td>
            </tr>
            <tr>
              <td style="width: 50%;">
                <div>&#160;</div>
              </td>
              <td style="width: 50%;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%;">August 26, 2022<br>
              </td>
              <td style="width: 50%;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-3</font> </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>btx-20220721.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<xs:schema targetNamespace="http://brooklynitx.com/20220721" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:btx="http://brooklynitx.com/20220721" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="btx-20220721_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="btx-20220721_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://brooklynitx.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>btx-20220721_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>btx-20220721_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="btx-20220721.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>logo01.jpg
<TEXT>
begin 644 logo01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !  /X# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#U3XD?%&;P
M7XNMM,?3X[BREM1,TH8^8C%F'3H0,=./K7,WOQB\1QVS7FG:7I.I:>O+3V[2
M;H_^NB'YD_'CWKG?VE_^1^M/^P>G_H;UYQX9N_L'B'3[C]Z5$Z*ZQ2&-G4G!
M&X?6O<H8.E*BJC6MCPJ^,JQK.FGI<]GT_P"-NL:GILAL-*T]]4AW.]J7?]]%
M_>C]6'.5ZXY'>H?#_P <]8U/6K.RETK3D2X?RPRNY()!V_KBNB\2_#C1)_$>
MC/:Z;=Z?<3RNS2VEPJ,61"P8=@<C)(%,USX;:+I^KV6N+97ZW!OK?=&MQ&J,
MS. 6P.A)Y.,#-<RGA'?W=SI<,7?XMC E^..M1:!:7SZ1IXGN+B6()O? 5%7)
MZYSEL?A4NC?&S6+F.:]U'2M/M]*MSB256<M(_:.,=W/Y <FMO7/AGH=_JNFZ
M4-.OK:%(+BX!ANEW%C(F>N>[?RJ'Q#\-=&74O#L+V=^;,S_9EM#<J(POELQ(
MQSN)4$L3D_E0IX5JW+J#ABT[\VAAZ9\;/%&J2NMCX?TYD3EY'E=8XE]7<D 5
M8OOCM<VT<<$%E87MZS@/+$76!1GHI/S.??@?6N:^/=G;:/J&DZ3IUD]A:>09
MS )<QGYMHPHXSP>3R<UY;#_KXO\ ?7^==E+"4:T/:*-D<=3%5Z4_9N5V?>49
MRH/J,TZFQ_<7Z"N6^*<M_!\/];FTAYTOHX=\;09WKA@21CVS7A1CS243WI2Y
M8\QU=%?&VD^*/'&KWBVFEZUK%U<N"RQ1SDL0.N*WOL_Q:_ZF7_OL_P"->A++
MG%VE-(\^.9*2O&#9]5YHKY5TSXB^./!>LI!X@-Y<1\/):7X^9D/=6Z@_F*^F
M]#U6VUK2+34K!]]M=1+*A[X/8^XZ5S5\-.A9O5/JCIP^*C7NEHUT+]%)FC-<
MQTBT4F:7- !11FC- !1FDS7GWQRUC4-#\!R7ND74EI="YB02QXSM)Y'-73@Z
MDE!=2*DU3BYOH>A9HKSGX$ZUJ.O>"6O-9NY+NZ%W)'YDF,[0%P./K7HV:*D'
M3FX/H%.HJD%-=0SBC-<'\;-7O]$\ 75]I-U):W:S1*LJ8R 7 /6LG]G_ %_5
M/$'AK4;C6[V6\FCN_+1Y,9"[%..!ZDU:HR=+VO2]B'7BJOLNNYZE129I:Q-@
MHI,T9H 6BDS2YH ^8OVE_P#D?K3_ +!Z?^AO7EE@0-0M"?\ GO'_ .A"O9/V
MAK.PD\;6EQJ6HB!!8HH@AC,DS_.W('"@>Y->;Z?K%I9ZA:+HVF11,9D'VF[Q
M/-]X= ?E7\!^-?28:;^K))7T/FL5'_:&V^I]1:SJ$1\1>'SY-_\ ++/G,+Y_
MU1Z<4SQC?Q/I]F!#J QJ%J?FA<?\M5]JU]<1QKFASA6,4#3O(P_A'E$?S-8N
MH:U'X@LHTLXV)AU"W=><^9&DR;G'L"<?A7@15];'O2DE>+>K)KC4(O\ A,[%
MO)U# L)QCR7S_K(O:HO$M_$VJ^&R(=0&V_)^:%\G]S)TK6U:0VOB:VOG4^1%
M8S1ELXR[21;5^IQ66VI#Q!)X>O+2-@D.H9F4]8\Q2#!]P3BG%?:MH*4DGRWU
M/%?VCYUG\7:6R+.H%CC$R%3_ *QO6O*H?]=%_OK_ #%>W_M&:F+3Q9IEO<6-
MI>VSV6XI,F'!WMRKC##^7M7ED-IHM_-$;&]ETZ;>I\B]&^,G/02J/_0A^->]
M@YVPZNCPL7&^(=GU/M:/[B_05!J-Y;6%G+<W\T<%M&,R22'"J.G)J:/[B_2N
M+^-G/PM\0?\ 7%?_ $-:^=A'FDH]SZ*<N6#EV1X1\5=*TC1M>BUWP5K%H8I)
M=YAM9AOMI>NY<?PG]/I7KWPW^*VE:YH8_M^\MM/U2WPDPE<(LO\ MKGU[CM7
MAOPO\!'QU=:A$E^+(VB(V3%OW;B1ZCTKT$_L]R'KXA0_]NO_ -E7M8A8?E5&
MK+5=;'C8=XCF=6E'1]#&_:&\4Z-K]_I=OH\T5W)9B0S7,?*C=C" ]^F:VKB]
MUGPK^SSHMQ97<UE>O<*RLHPRQN[L!SV(P:\Z^(G@:_\  .IV8GFBNK>;YX)@
MG!*D95E/X<="*].^*&O+XE^!.EZJ$2-YKF$2(G1'7<K >V11*,%"E"&L;BC*
M3G5G/25CA])^(7C[7+:'0](NKBYO7=I&FC0&9EXXSC"J/7WKU67QC?\ P_\
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MC-8SZ=\&Y;:\OIK^Y26#S+F;&Z1MXR>.@]!7 > #K$/P9\0WOAZ\FM+VSO\
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MWV2 #ED ^:1O1>P]3GL*Z8U.3!)K>QSRASXVS[GNGQ"%Q)X;>&TD,;SRI$S
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M MWJ4T]C+>"[1$ C<+MVDGO]:]'_ .&@[+_H7[K_ ,"%_P *[?\ X5/X*_Z
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:U4C&$-$CCP]"5.4ISW84445RG4%%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139769428819760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 21, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 21,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-11460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Brooklyn ImmunoTherapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000748592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-1103425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10355 Science Center Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">582-1199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.005 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BTX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>brhc10041542_8ka_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="btx-20220721.xsd" xlink:type="simple"/>
    <context id="c20220721to20220721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2022-07-21</startDate>
            <endDate>2022-07-21</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20220721to20220721"
      id="Fact_e6353bdccf7a4d55a4670c8333bdf6a9">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20220721to20220721"
      id="Fact_53451111fb104cc593f8f9689ed5f5bf">0000748592</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20220721to20220721"
      id="Fact_45e7f56145994bde9ece646b6a545f88">8-K/A</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20220721to20220721"
      id="Fact_ab6f138dbfa34364a905bc48218a4e0a">2022-07-21</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20220721to20220721"
      id="Fact_a2b576c7b9af49f4a620a68e99b7eb9d">Brooklyn ImmunoTherapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20220721to20220721"
      id="Fact_1e94b3adbcf240dabfd703a55431e0b7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20220721to20220721"
      id="Fact_ad564dabd9dd41c5ac5eb1b6fec558ff">001-11460</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20220721to20220721"
      id="Fact_b5e128b4d88248268adc425475c3412c">31-1103425</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20220721to20220721"
      id="Fact_08b412bebb9b4e30a65700a8fa329d3e">10355 Science Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20220721to20220721"
      id="Fact_284b9f8fecbe4831a72ca4aa1afadcb5">Suite 150</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20220721to20220721"
      id="Fact_2bb0fe8eebdb4a0e81fb3adce5b04541">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20220721to20220721"
      id="Fact_1053604ccc7b415c8ce3c745abae5965">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20220721to20220721"
      id="Fact_789ed306c1364c8d9f820a1cc9ba6588">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20220721to20220721"
      id="Fact_e4365b52fb5b45e2a1f850ef9b760555">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20220721to20220721"
      id="Fact_f27da2b4bce84ea7be8936a6c7dce801">582-1199</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20220721to20220721"
      id="Fact_c02819d27e8742c8a7d8933d7e7ee3f3">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20220721to20220721"
      id="Fact_ea797d60a11b40eaac9281c62dd00ea5">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20220721to20220721"
      id="Fact_bcada7defb2e483a9c6f9caa4cbb99c4">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20220721to20220721"
      id="Fact_d959178f5c274dbab908731f8b2d6d2b">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20220721to20220721"
      id="Fact_919bb5812fde4c8a8baed9df2a03f4d6">Common Stock, par value $0.005 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220721to20220721"
      id="Fact_4f7384b65601471c9b1ee52d2e1c7a99">BTX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20220721to20220721"
      id="Fact_13b86bbdaffe41f4ba6414cd8699bc1c">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20220721to20220721"
      id="Fact_ed1ccead57fb48d3a7365fa9b04f83db">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q
M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"
MIQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " "CA2%5EXJ[',
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M(54<.&7J/P$  #P"   /    >&PO=V]R:V)O;VLN>&ULC5'+;L) #/R5U7Y
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M%0:P;W(@"2[)E1M27>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04
M" "CA2%5)!Z;HJT   #X 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QSM9$]#H,P#(6O$N4 -5"I0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM
M?^_)3I]H%'=NH+;S)$9K!LIDR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(H
MND'8,V2>[IFBG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++
M3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$
M%     @ HX4A5660>9(9 0  SP,  !,   !;0V]N=&5N=%]4>7!E<UTN>&UL
MK9--3L,P$(6O$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QX
MWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#
M4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$
MJ+EST&!G(BY84(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:
M!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U5
M9"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\
MUDX:?^:+X3]>?P%02P$"% ,4    " "CA2%5!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( *.%(56\
MJ.M0[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( *.%(5697)PC$ 8  )PG   3              "  <P!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ HX4A54/8[&=R!
M31$  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( *.%(56?H!OPL0(  .(,   -              "  ;4,
M  !X;"]S='EL97,N>&UL4$L! A0#%     @ HX4A59>*NQS     $P(   L
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64$L%!@     )  D /@(  !44      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc10041542_8ka.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K/A" original="brhc10041542_8ka.htm">brhc10041542_8ka.htm</File>
    <File>brhc10041542_ex10-1.htm</File>
    <File>btx-20220721.xsd</File>
    <File>btx-20220721_lab.xml</File>
    <File>btx-20220721_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10041542_8ka.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "brhc10041542_8ka.htm"
     ]
    },
    "labelLink": {
     "local": [
      "btx-20220721_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "btx-20220721_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "btx-20220721.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "btx",
   "nsuri": "http://brooklynitx.com/20220721",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10041542_8ka.htm",
      "contextRef": "c20220721to20220721",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://brooklynitx.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10041542_8ka.htm",
      "contextRef": "c20220721to20220721",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001140361-22-031997-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-22-031997-xbrl.zip
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MA/0DESV[QWK4L1W?==<PE&[KM\[QHHW<U?R-9?/?G^(6<A&WB?GF1^:"I50
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MY!. %,8;(N@DJ[@+T.DBCJA$ZG'SX6#JH8VC@A"5*65Y&JA$&S5(J(*Z!U^
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M-30R7V5X,3 M,2YH=&WM?6E3&\FRZ/<7\?Y#'9_K>R%"8*V \,Q$8)!M[MA
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M8;?3[;#_!UL>[K(U^++.!CO=C4YG.(2KG@Y@E-FW35 (GD'L_6<.L@>Z8((
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M6N=8!?9K2V$:WA:4(B/).C/".LQ-?W+C.<V/4>'.,*&=L?;#$UXD:%JD[-*
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M4\S?/-U<K82XQU%%=OD'4$L#!!0    ( *.%(558LES*?P@  '18   4
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MD@GJ@-SN3MUGF^"1;08&'HBQ2913N"QQ<!HO&[H^E0/>5:=S+64F(DB$>O!
MC'7#2+T%AL_L9;5Z=M>=BG<XEM;BDGWB;_XMFL+\3;FS_P%02P,$%     @
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M@OS?\TU$_I#_J_WA?U!+ 0(4 Q0    ( *.%(54P-1Y?Z1<  /B2   4
M          "  0    !B<FAC,3 P-#$U-#)?.&MA+FAT;5!+ 0(4 Q0    (
M *.%(56IYVEB6"\  $@/ 0 7              "  1L8  !B<FAC,3 P-#$U
M-#)?97@Q,"TQ+FAT;5!+ 0(4 Q0    ( *.%(56:FR&)2 ,  #\/   0
M          "  :A'  !B='@M,C R,C W,C$N>'-D4$L! A0#%     @ HX4A
M55BR7,I_"   =%@  !0              ( !'DL  &)T>"TR,#(R,#<R,5]L
M86(N>&UL4$L! A0#%     @ HX4A5;7[^U7?!0  ]CX  !0
M ( !SU,  &)T>"TR,#(R,#<R,5]P<F4N>&UL4$L%!@     %  4 20$  .!9
$      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
